Mortality due to bleeding, myocardial infarction and stroke in dialysis patients

Essentials Mortality due to bleeding vs. arterial thrombosis in dialysis patients is unknown. We compared death causes of 201 918 dialysis patients with the general population. Dialysis was associated with increased mortality risks of bleeding and arterial thrombosis. Clinicians should be aware of the increased bleeding and thrombosis risks.

[1]  D. Bacquer,et al.  Vitamin K antagonists for stroke prevention in hemodialysis patients with atrial fibrillation: A systematic review and meta-analysis. , 2017 .

[2]  A. Iorio,et al.  Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta‐analysis of randomized controlled trials , 2015, Journal of thrombosis and haemostasis : JTH.

[3]  Jenny I. Shen,et al.  Outcomes After Warfarin Initiation in a Cohort of Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  Gaosi Xu,et al.  Warfarin use and the risks of stroke and bleeding in hemodialysis patients with atrial fibrillation: A systematic review and a meta-analysis. , 2015, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[5]  A. Szabo,et al.  Gastrointestinal bleeding in patients on long-term dialysis , 2015, Journal of Nephrology.

[6]  A. Santoro,et al.  Warfarin use, mortality, bleeding and stroke in haemodialysis patients with atrial fibrillation. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[7]  I. Narita,et al.  Association between warfarin use and incidence of ischemic stroke in Japanese hemodialysis patients with chronic sustained atrial fibrillation: a prospective cohort study , 2014, Clinical and Experimental Nephrology.

[8]  T. Wang,et al.  Relationships between Anticoagulation, Risk Scores and Adverse Outcomes in Dialysis Patients with Atrial Fibrillation. , 2014, Heart, lung & circulation.

[9]  Jung-Der Wang,et al.  Risk of stroke in long-term dialysis patients compared with the general population. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[10]  J. Tu,et al.  Warfarin Use and the Risk for Stroke and Bleeding in Patients With Atrial Fibrillation Undergoing Dialysis , 2014, Circulation.

[11]  Chun-Yuh Yang,et al.  The risk of upper gastrointestinal bleeding in patients treated with hemodialysis: a population-based cohort study , 2013, BMC Nephrology.

[12]  C. Clase,et al.  Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  L. Køber,et al.  Stroke and bleeding in atrial fibrillation with chronic kidney disease. , 2012, The New England journal of medicine.

[14]  M. Desai,et al.  Trends in acute nonvariceal upper gastrointestinal bleeding in dialysis patients. , 2012, Journal of the American Society of Nephrology : JASN.

[15]  W. Winkelmayer,et al.  Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[16]  R. Luqmani,et al.  Pulmonary-renal syndromes: an update for respiratory physicians. , 2011, Respiratory medicine.

[17]  A. Algra,et al.  Excess Mortality and Cardiovascular Events in Patients Surviving Subarachnoid Hemorrhage: A Nationwide Study in Sweden , 2011, Stroke.

[18]  Frits R Rosendaal,et al.  Cardiovascular and noncardiovascular mortality among patients starting dialysis. , 2009, JAMA.

[19]  R. Thadhani,et al.  Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. , 2009, Journal of the American Society of Nephrology : JASN.

[20]  N. Powe,et al.  Cerebrovascular disease incidence, characteristics, and outcomes in patients initiating dialysis: the choices for healthy outcomes in caring for ESRD (CHOICE) study. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  R. Collins,et al.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. , 2009, Lancet.

[22]  R. Thadhani,et al.  Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients. , 2009, Journal of the American Society of Nephrology : JASN.

[23]  R. Écochard,et al.  Effect of age, gender, and diabetes on excess death in end-stage renal failure. , 2007, Journal of the American Society of Nephrology : JASN.

[24]  A. R. Morton,et al.  Warfarin and aortic valve calcification in hemodialysis patients. , 2007, Journal of nephrology.

[25]  C Zoccali,et al.  Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective. , 2006, Kidney international.

[26]  B. Fivush,et al.  Incidence of atherosclerosis by race in the dialysis morbidity and mortality study: a sample of the US ESRD population. , 2005, Journal of the American Society of Nephrology : JASN.

[27]  J. Manson,et al.  A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women , 2005, The New England journal of medicine.

[28]  M. Rocco,et al.  Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. , 2004, Kidney international.

[29]  B. Kestenbaum,et al.  Risk factors for upper gastrointestinal bleeding among end-stage renal disease patients. , 2003, Kidney international.

[30]  B. Kestenbaum,et al.  Risk factors for incident stroke among patients with end-stage renal disease. , 2003, Journal of the American Society of Nephrology : JASN.

[31]  B. Kestenbaum,et al.  Elevated risk of stroke among patients with end-stage renal disease. , 2003, Kidney international.

[32]  Allen J. Taylor,et al.  Incident acute coronary syndromes in chronic dialysis patients in the United States. , 2002, Kidney international.

[33]  R Cornet,et al.  Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[34]  M. Roncaglioni.  Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general Practice , 2001, The Lancet.

[35]  F. Dekker,et al.  The European Registry: Where do We Stand? , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[36]  R. Foley,et al.  Epidemiology of cardiovascular disease in chronic renal disease , 2000 .

[37]  R. Foley,et al.  Clinical epidemiology of cardiovascular disease in chronic renal disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[38]  Joël Ménard,et al.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.

[39]  R. Wolfe,et al.  Causes of death in dialysis patients: racial and gender differences. , 1994, Journal of the American Society of Nephrology : JASN.

[40]  J. Sixma,et al.  Thrombosis and hemostasis in renal disease. , 1994, Kidney international.

[41]  G. Escolar,et al.  Recombinant human erythropoietin treatment improves platelet function in uremic patients. , 1992, Kidney international.

[42]  G. Remuzzi.  BLEEDING IN RENAL FAILURE , 1988, The Lancet.

[43]  G. Remuzzi,et al.  URAEMIC BLEEDING: ROLE OF ANAEMIA AND BENEFICIAL EFFECT OF RED CELL TRANSFUSIONS , 1982, The Lancet.

[44]  G. Eknoyan,et al.  Platelet function in renal failure. , 1969, The New England journal of medicine.

[45]  Cole Pv.  Treatment of Reflux Oesophagitis , 1964 .

[46]  J. Lutz,et al.  Haemostasis in chronic kidney disease. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[47]  G. Beck,et al.  Cerebrovascular disease in maintenance hemodialysis patients: results of the HEMO Study. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[48]  G. de Gaetano.  Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project. , 2001, Lancet.

[49]  G. Escolar,et al.  Defective platelet adhesion on vessel subendothelium in uremic patients. , 1986, Blood.